TABLE 3.
pA2 of antagonists for cAMP production mediated by CTR and AMY1 receptors
NS, no significance compared with the template peptide used for mutagenesis. Analysis of variance with Tukey's post hoc test was used for statistical analysis.
Peptide | CTR with hCT agonist |
AMY1 with rAmy agonist |
AMY1 with hCT agonist |
||||||
---|---|---|---|---|---|---|---|---|---|
n | Mean | S.E. | n | Mean | S.E. | n | Mean | S.E. | |
AC413(6–25) | 3 | 7.04 | 0.03 | 7 | 7.43 | 0.09 | 4 | 7.19 | 0.11 |
AC413(6–25) Y25P | 3 | 8.48a | 0.01 | 4 | 8.03a | 0.08 | 4 | 8.71a | 0.11 |
AC413(6–25) Y25A | 3 | 7.16NS | 0.16 | 4 | 6.53a | 0.08 | 3 | 7.31NS | 0.15 |
rAmy(8–37) | 3 | <5.2 | 3 | 5.98 | 0.09 | 3 | <5.2 | ||
rAmy(8–37) Y37P | 3 | 6.73 | 0.02 | 3 | 7.52b | 0.11 | 3 | 6.83 | 0.10 |
rAmy(8–37) Y37A | 3 | 5.33 | 0.11 | 3 | 6.02NS | 0.03 | 3 | 5.46 | 0.14 |
a p < 0.05 compared with AC413(6–25).
b p < 0.05 compared with rAmy(8–37).